p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 27, Issue 3, Pages 187-198
Publisher
Bioscientifica
Online
2020-01-29
DOI
10.1530/erc-19-0488

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.